Safety evaluation of ruxolitinib for treating myelofibrosis

Sofia Galli, Donal McLornan, Claire Harrison*

*Corresponding author for this work

Research output: Contribution to journalLiterature reviewpeer-review

21 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Safety evaluation of ruxolitinib for treating myelofibrosis'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science